HomeCompareCEMI vs MO

CEMI vs MO: Dividend Comparison 2026

CEMI yields 439.56% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CEMI wins by $23009.93M in total portfolio value
10 years
CEMI
CEMI
● Live price
439.56%
Share price
$0.46
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23010.00M
Annual income
$15,896,080,726.35
Full CEMI calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — CEMI vs MO

📍 CEMI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCEMIMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CEMI + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CEMI pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CEMI
Annual income on $10K today (after 15% tax)
$37,362.64/yr
After 10yr DRIP, annual income (after tax)
$13,511,668,617.40/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, CEMI beats the other by $13,511,643,994.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CEMI + MO for your $10,000?

CEMI: 50%MO: 50%
100% MO50/50100% CEMI
Portfolio after 10yr
$11505.04M
Annual income
$7,948,054,847.45/yr
Blended yield
69.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

CEMI
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
-3.4
Piotroski
5/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CEMI buys
0
MO buys
0
No recent congressional trades found for CEMI or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCEMIMO
Forward yield439.56%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$23010.00M$77.7K
Annual income after 10y$15,896,080,726.35$28,968.54
Total dividends collected$22371.64M$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: CEMI vs MO ($10,000, DRIP)

YearCEMI PortfolioCEMI Income/yrMO PortfolioMO Income/yrGap
1← crossover$54,656$43,956.04$10,558$768.31+$44.1KCEMI
2$283,011$224,529.30$11,352$1,015.87+$271.7KCEMI
3$1,389,385$1,086,562.63$12,482$1,367.86+$1.38MCEMI
4$6,471,924$4,985,282.48$14,103$1,883.39+$6.46MCEMI
5$28,627,815$21,702,856.71$16,472$2,664.91+$28.61MCEMI
6$120,351,485$89,719,722.14$20,024$3,897.79+$120.33MCEMI
7$481,282,796$352,506,707.51$25,537$5,933.74+$481.26MCEMI
8$1,832,417,590$1,317,444,998.11$34,478$9,476.77+$1832.38MCEMI
9$6,648,527,352$4,687,840,530.71$49,776$16,022.63+$6648.48MCEMI
10$23,010,004,993$15,896,080,726.35$77,699$28,968.54+$23009.93MCEMI

CEMI vs MO: Complete Analysis 2026

CEMIStock

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.

Full CEMI Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this CEMI vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CEMI vs SCHDCEMI vs JEPICEMI vs OCEMI vs KOCEMI vs MAINCEMI vs PMCEMI vs BTICEMI vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.